Dow Up 0.41% Nasdaq Up 1.15%

Dynavax Technologies Corporation (DVAX)

-NasdaqCM
1.52 Up 0.01(0.33%) 10:07AM EDT - Nasdaq Real Time Price
Prev Close:1.51
Open:1.51
Bid:1.51 x 7600
Ask:1.52 x 7700
1y Target Est:4.50
Beta:4.03
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:1.49 - 1.52
52wk Range:1.10 - 2.14
Volume:71,508
Avg Vol (3m):1,476,970
Market Cap:398.26M
P/E (ttm):N/A
EPS (ttm):-0.32
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for DVAX

Comparison

Symbol% ChgMkt Cap
DVAXUp 0.33%398.26M
GSKDown 0.64%104.08B
MRKUp 0.95%157.40B
RHHBYUp 0.99%246.01B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):32.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.34
Quarterly EPS Est (Sep-14) :-0.09
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases, and cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback